Intrinsic Value

The intrinsic value of IntroMedic Co Ltd (150840) under the Base Case is 14 444.32 KRW per share. Compared with the current market price of 5 850 KRW, the stock appears Undervalued by 59% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

Intrinsic Value
₩14 444.32
Undervaluation 59%
Intrinsic Value
Price ₩5 850
I

IntroMedic Co Ltd is valued in line with its history. A discount of this size has been typical over the past 5 years.

Monitor IntroMedic Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ₩11 555.46
Get notified when the price drops into your buy zone
Intrinsic Value ₩14 444.32
Margin of Safety 20% ₩11 555.46
Current Price ₩5 850
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to IntroMedic Co Ltd

Fundamental Analysis

What IntroMedic Does

Health Care

IntroMedic Co., Ltd. is a Korea-based company mainly engaged in the development, manufacture and distribution of medical equipment. The Company’s products consist of capsule endoscope, which is used for small intestine check under the brand name MiroCam; disposable endoscope, which is used to detect abnormalities of the esophagus and the stomach under the brand name E.G. Scan, and other accessories, such as abdominal disposable data belts and others. The Company distributes its products within domestic market and to overseas markets.

Headquarters
Korea KR
IPO date
Dec 19, 2013
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
IntroMedic Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one IntroMedic Co Ltd stock?

The intrinsic value for IntroMedic Co Ltd (150840) under the Base Case is 14 444.32 KRW.

Is IntroMedic Co Ltd stock undervalued or overvalued?

Compared with the current market price of 5 850 KRW, the stock appears Undervalued by 59% .

Back to Top